We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
NYSE:GSK
​
​
logo

GSK (GSK)

NYSE • GSK • US37733W2044

Ex-dividend 13 Nov · 0.444326 USD (special)
48.70Last close
Market Closed
Ex-dividend 13 Nov · 0.444326 USD (special)
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Nov 3, 2026, ORTEX estimates 0.7% of free float is sold short, 2.5 days to cover, cost to borrow 0.49%.

Market Cap

98.3b USD | # 220 in US

Volume

4.04m shares | 201m USD

Shares Outstanding

2b

Free Float Shares

96.89% | 1.94b

OTCPK:GLAX.F|
DB:GS70|
DB:GS71|
XTRA:GS71|
LSE:GSK|
BOVESPA:G1SK34|
BASE:GSK|
BASE:GSKD|
BASE:GSKD

News

GSK key data

GSK (NYSE: GSK) has a market capitalization of $98.26B. Last close $48.70 (as of 2026-11-04); 52-week range $45.81 to $61.70. ORTEX data as of 2026-11-03: short interest is 0.71% of free float, 2.5 days to cover and the average cost to borrow is 0.49%.

  • GSK news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.